A1 Journal article – refereed

A biomarker-based study of prenatal smoking exposure and autism in a Finnish national birth cohort




List of Authors: Cheslack-Postava Keely, Sourander Andre, Hinkka-Yli-Salomäki Susanna, McKeague Ian W., Surcel Heljä-Marja, Brown Alan S.

Publisher: WILEY

Publication year: 2021

Journal: Autism Research

Journal acronym: AUTISM RES

Number of pages: 10

ISSN: 1939-3792

eISSN: 1939-3806

DOI: http://dx.doi.org/10.1002/aur.2608


Abstract

Maternal exposure to tobacco smoke during pregnancy is a common and persistent exposure linked to adverse neurodevelopmental outcomes in the offspring. However, previous studies provide mixed evidence regarding the relationship between prenatal smoking and offspring autism. This study used cotinine level, a biomarker for nicotine, to investigate the relationship between prenatal smoking and autism. The authors conducted a population-based case-control study nested in a national cohort of all births in Finland from 1987 to 2005. Cases diagnosed with childhood autism (ICD-10/9 code F84.0/299.0) through 2007 were identified using data from linked national registers. Each case was matched with a control on date of birth (+/- 30 days), sex, and place of birth (N = 962 pairs). Maternal serum cotinine levels were prospectively measured in first- to early second-trimester serum samples archived in a national biobank using a quantitative immunoassay. Data were analyzed using conditional logistic regression. Prenatal maternal levels of serum cotinine were not associated with the odds of autism, whether cotinine was classified continuously, by deciles, or using previously defined categories corresponding to probable maternal smoking status. After adjusting for maternal age, paternal age, previous births, and any history of parental psychiatric disorder, the odds ratio for categorical high versus low cotinine, using a 3-level exposure variable, was 0.98 (95% CI = 0.76, 1.26; p = 0.88). In conclusion, this national birth cohort-based study does not provide evidence for an association between maternal cotinine, a biomarker of maternal smoking, and risk of autism.


Last updated on 2021-15-10 at 12:56